Sleep Apnea Determines Soluble TNF-α Receptor 2 Response to Massive Weight Loss
- 6 February 2011
- journal article
- research article
- Published by Springer Nature in Obesity Surgery
- Vol. 21 (9) , 1413-1423
Abstract
The effects of surgical weight loss (WL) on inflammatory biomarkers associated with sleep apnea remain unknown. We sought to determine if any biomarkers can predict amelioration of sleep apnea achieved by bariatric surgery. We hypothesized that surgical WL would substantially reduce severity of sleep apnea and levels of proinflammatory cytokines.Keywords
This publication has 32 references indexed in Scilit:
- C‐reactive protein evolution in obstructive sleep apnoea patients under CPAP therapyEuropean Journal of Clinical Investigation, 2010
- The roles of TNF-α and the soluble TNF receptor I on sleep architecture in OSASleep and Breathing, 2009
- Effects of continuous positive airway pressure on systemic inflammation in patients with moderate to severe obstructive sleep apnoea: a randomised controlled trialThorax, 2008
- Selective effects of CPAP on sleep apnoea‐associated manifestationsEuropean Journal of Clinical Investigation, 2008
- Upper airway neuromuscular compensation during sleep is defective in obstructive sleep apneaJournal of Applied Physiology, 2008
- CPAP decreases plasma levels of soluble tumour necrosis factor-α receptor 1 in obstructive sleep apnoeaEuropean Respiratory Journal, 2008
- Interleukin-6 and Tumor Necrosis Factor-α in Patients with Obstructive Sleep Apnea-Hypopnea SyndromeRespiration, 2004
- The Effects of a High-protein, Low-fat, Ketogenic Diet on Adolescents With Morbid Obesity: Body Composition, Blood Chemistries, and Sleep AbnormalitiesPediatrics, 1998
- Elevation of Plasma Cytokines in Disorders of Excessive Daytime Sleepiness: Role of Sleep Disturbance and ObesityThe Journal of Clinical Endocrinology & Metabolism, 1997
- Interleukin-8 and the chemokine familyInternational Journal of Immunopharmacology, 1995